Synchrogenix, a Certara company Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Synchrogenix, a Certara company's estimated annual revenue is currently $60.1M per year.
- Synchrogenix, a Certara company's estimated revenue per employee is $201,000
- Synchrogenix, a Certara company has 299 Employees.
- Synchrogenix, a Certara company grew their employee count by -8% last year.
- Synchrogenix, a Certara company currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
What Is Synchrogenix, a Certara company?
PROVIDING REGULATORY STRATEGY, SCIENCE, and SERVICES to PHARMACEUTICAL, DEVICE/DIAGNOSTICS, and TOBACCO COMPANIES WORLDWIDE REGULATORY STRATEGY - Strategic cross-functional guidance and comprehensive implementation - Submission and Program Leadership - Strategic messaging alignment, overall Vendor strategy and management, agency communications - Modules 1-5 of the Common Technical Document (CTD) / PMA, 510k / PMTA, TPMF, MRTP - Regulatory Operations REGULATORY and MEDICAL WRITING By merging our cross-functional expertise with our writing and operations experience, we deliver documents that not only support clients strategic messaging, but also enhance their marketability. We provide many of the benefits of an in-house teamincluding the experience and perspective of industry insiderswithout increased overhead or struggles with fluctuating workloads. Synchrogenix provides clients with objective, professional document review services. Our rigorous quality-control process includes checks of data, formatting, spelling, grammar, and clarity. Our team includes industry experts, medical doctors, and clinicians who provide our clients with objective content review. TECHNOLOGY-ENABLED SERVICES - GlobalSubmit Regulatory operations technology - ClinGenuity Artificial intelligence technology platform TRANSPARENCY and DISCLOSURE Our disclosure team consults with our clients to educate cross-functional teams as to the requirements for and compliance to FDAAA, FDAMA, and EMA's policies 43 and 70. We develop a roadmap for compliance for our domain experts to fulfill in tandem with client stakeholders. - Global Trial and Results Registries - Redaction and Dataset De-Identification - Plain Language Summaries, in partnership with CISCRPkeywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Linda Tabas||Associate Director, Publications And Publications Planning||Email Available|
|Ann Benesh||Principal Writer||Email Available|
|Valerie Breda||Associate Principal Writer||Email Available|
|Jessica Walsh||Sr. Marketing Operations Manager||Email Available|
|Jen Bruhler||Director, Proposals & Contracts||Email Available|
|Bob Bowden||Director Of Information Technology||Email Available|
|Mark Bowlby||Associate Director, Global Submissions||Email Available|
|Kori Lambert||Director (Division Head of Finance and Accounting)||Email Available|
|David Meats||Associate Director Of Submission Operations||Email Available|
|Evan Richardson||Director, Regulatory Services||Email Available|
Synchrogenix, a Certara company Executive Hires
|2014-10-24||Kelley Hill||Dir Cambridge, MA||Article|
Synchrogenix, a Certara company New Location/Offices